Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell wall synthesis enzymes in Cutibacterium acnes are responsible for constructing its unique peptidoglycan-rich cell wall, which enables the bacterium to survive on human skin and in anaerobic environments. The cell wall features distinct biochemical characteristics, such as peptide chains incorporating L-diaminopimelic acid and D-alanine, setting it apart from other Gram-positive bacteria[3]. This target is of particular therapeutic interest because inhibiting cell wall synthesis halts bacterial replication and disrupts biofilm formation, making it a principal focus for classic antibiotics and novel anti-acne treatments. Importantly, biofilm formation contributes to heightened resistance against antimicrobials, persistent inflammation, and device-associated infections, underscoring the medical significance of this target[2][3][5].
Inhibition of peptidoglycan crosslinking; Inhibition of glycosyltransferase enzymes; Inhibition of uridine diphosphate N-acetylglucosamine 2-epimerase (essential for cell wall sugar biosynthesis)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall synthesis enzyme in Cutibacterium acnes.